ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,811.80
-0.46%
S&P ASX All Technology
3,103.10
0.92%
Brent Oil
82.125
0.73%
US Dollar vs AUD
1.50853
-0.15%
Bitcoin
69,701.64
0.87%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kite Pharma, Inc. (KITE)

  7. Kite Pharma, Inc. (KITE) News

KITE

KITE PHARMA, INC. (KITE)

Kite Pharma, Inc.
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KITE
DateTimeSourceHeadlineSymbolCompany
14/10/201708:05Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:KITEKite Pharma, Inc.
06/10/201706:44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KITEKite Pharma, Inc.
04/10/201708:12Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
04/10/201708:07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
04/10/201708:02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
04/10/201707:57Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
04/10/201707:56Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:KITEKite Pharma, Inc.
04/10/201707:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
04/10/201700:03Edgar (US Regulatory)(25-NSE)NASDAQ:KITEKite Pharma, Inc.
03/10/201723:46Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
03/10/201723:45Business WireGilead Sciences Completes Acquisition of Kite Pharma, Inc.NASDAQ:KITEKite Pharma, Inc.
03/10/201723:17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
03/10/201723:00Business WireGilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.NASDAQ:KITEKite Pharma, Inc.
26/09/201722:54Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
26/09/201722:40Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
26/09/201722:30Business WireGilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting PeriodNASDAQ:KITEKite Pharma, Inc.
26/09/201707:17Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
26/09/201707:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
26/09/201706:31Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
23/09/201706:18Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
19/09/201707:29Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
16/09/201706:52Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
09/09/201707:30Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
09/09/201707:24Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
09/09/201703:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KITEKite Pharma, Inc.
08/09/201706:12Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
06/09/201706:13Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:KITEKite Pharma, Inc.
06/09/201706:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
06/09/201702:24Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:KITEKite Pharma, Inc.
02/09/201707:28Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:KITEKite Pharma, Inc.
 Showing the most relevant articles for your search:NASDAQ:KITE

Your Recent History

PM
XAUUSD
Gold vs US Dollar
FX
AUDUSD
AUD vs US Dollar
NASDAQ
TSLA
Tesla
NYSE
XOM
Exxon Mobil
SPI
SP500
S&P 500
ASX
CSL
CSL
ASX
WES
Wesfarmers
ASX
WOW
Woolworths
ASX
AMP
AMP
NASDAQ
NVDA
NVIDIA
ASX
TLS
Telstra
ASX
WDC
Westfield
NASDAQ
AMZN
Amazon.com
ASX
WBC
Westpac Banking
ASX
QBE
QBE Insurance
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved